Screener
Neuropace, Inc. NPCE EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s EBITDA margin?
- Neuropace, Inc. (NPCE) reported EBITDA margin of -14.9% in Q2 2026.
- How has Neuropace, Inc.'s EBITDA margin changed year-over-year?
- Neuropace, Inc.'s EBITDA margin increased by 39.8% year-over-year, from -24.8% to -14.9%.
- What is the long-term trend for Neuropace, Inc.'s EBITDA margin?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s EBITDA margin has grown at a -10.1% compound annual growth rate (CAGR), from -30.9% to -18.1%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Neuropace, Inc.'s ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude